======= FUCA1 ======= == Gene Information == * **Official Symbol**: FUCA1 * **Official Name**: alpha-L-fucosidase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2517|2517]] * **UniProt**: [[https://www.uniprot.org/uniprot/P04066|P04066]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FUCA1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FUCA1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612280|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a lysosomal enzyme involved in the degradation of fucose-containing glycoproteins and glycolipids. Mutations in this gene are associated with fucosidosis (FUCA1D), which is an autosomal recessive lysosomal storage disease. A pseudogene of this locus is present on chr 2.[provided by RefSeq, Oct 2009]. * **UniProt Summary**: Alpha-L-fucosidase is responsible for hydrolyzing the alpha-1,6-linked fucose joined to the reducing-end N- acetylglucosamine of the carbohydrate moieties of glycoproteins. |Alpha L fucos| |alpha-L-fucosidase activity| |glycoside catabolic process| |glycolipid catabolic process| |fucose metabolic process| |glycoside metabolic process| |membrane lipid catabolic process| |glycosyl compound catabolic process| |glycosaminoglycan catabolic process| |aminoglycan catabolic process| |azurophil granule lumen| |lysosomal lumen| |glycolipid metabolic process| |liposaccharide metabolic process| |glycosyl compound metabolic process| |glycosaminoglycan metabolic process| |hexose metabolic process| |aminoglycan metabolic process| |carbohydrate derivative catabolic process| |cellular lipid catabolic process| |monosaccharide metabolic process| |membrane lipid metabolic process| |lysosome| |lipid catabolic process| |carbohydrate metabolic process| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |leukocyte mediated immunity| |exocytosis| |leukocyte activation| |cellular lipid metabolic process| |secretion by cell| |carbohydrate derivative metabolic process| |export from cell| |macromolecule catabolic process| |organonitrogen compound catabolic process| |cell activation| |immune effector process| |secretion| |lipid metabolic process| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp246|UM0011500 10μM R05 exp246]]|1.77| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|1.79| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8655 * **Expression level (log2 read counts)**: 3.48 {{:chemogenomics:nalm6 dist.png?nolink |}}